The influence of cardiopulmonary bypass on cytokines and cell-cell communication
Tóm tắt
Từ khóa
Tài liệu tham khảo
Beutler, 1987, Cachectin: More than a tumor necrosis factor, N Engl J Med, 316, 379, 10.1056/NEJM198702123160705
Dinarello, 1994, The interleukin family: 10 years of discovery, FASEB J, 8, 1314, 10.1096/fasebj.8.15.8001745
Billiau, 1991, Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock, Eur J Clin Invest, 21, 559, 10.1111/j.1365-2362.1991.tb01410.x
Dinarello, 1993, Anti-cytokine strategies in the treatment of the systemic inflammatory response syndrome, JAMA, 269, 1829, 10.1001/jama.1993.03500140081040
Casey, 1993, Roles of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure, Ann Thorac Surg, 56, s92, 10.1016/0003-4975(93)91143-B
Llamas, 1973, Respiratory distress syndrome in the adult after cardiopulmonary bypass, JAMA, 225, 1183, 10.1001/jama.1973.03220380015005
Jansen, 1992, Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass, Ann Thorac Surg, 54, 744, 10.1016/0003-4975(92)91021-Z
Andersen, 1993, Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass, Crit Care Med, 21, 210, 10.1097/00003246-199302000-00011
Tao, 1995, Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand, J Thorac Cardiovasc Surg, 110, 819, 10.1016/S0022-5223(95)70116-8
Oudemans-van Straaten, 1996, Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients, J Cardiothorac Vase Anesth, 10, 187, 10.1016/S1053-0770(96)80235-7
Martinez-Pellus, 1993, Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass?, Crit Care Med, 21, 1684, 10.1097/00003246-199311000-00017
Schumann, 1990, Structure and function of lipopolysaccharide binding protein, Science, 249, 1429, 10.1126/science.2402637
Wright, 1990, CD14, a receptor for complexes of lipopolysaccharide (LPS) binding protein, Science, 249, 1431, 10.1126/science.1698311
Dinarello, 1986, Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1, J Exp Med, 163, 1433, 10.1084/jem.163.6.1433
Schindler, 1990, Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF, Blood, 75, 40, 10.1182/blood.V75.1.40.40
Lowry, 1993, Cytokine mediators of immunity and inflammation, Arch Surg, 128, 1235, 10.1001/archsurg.1993.01420230063010
Journois, 1994, Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery, Anesthesiology, 81, 1181, 10.1097/00000542-199411000-00011
Menasché, 1994, A potential mechanism of vasodilation after warm heart surgery, J Thorac Cardiovasc Surg, 107, 293, 10.1016/S0022-5223(94)70484-8
Teoh, 1995, Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery, Circulation, 92, 11347, 10.1161/01.CIR.92.9.347
Haeffner-Cavaillon, 1989, Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass, J Thorac Cardiovasc Surg, 98, 1100, 10.1016/S0022-5223(19)34325-9
Tulla, 1991, Hypermetabolism after coronary artery bypass, J Thorac Cardiovasc Surg, 101, 598, 10.1016/S0022-5223(19)36687-5
Hennein, 1994, Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization, J Thorac Cardiovasc Surg, 108, 626, 10.1016/S0022-5223(94)70286-1
Kimmel, 1991, A final common pathway for anti-inflammatory agents: Inhibition of leukocyteendothelial interactions, Trans Assoc Am Physicians, 104, 113
Carlos, 1990, Membrane proteins involved in phagocyte adherence to endothelium, Immunol Rev, 114, 5, 10.1111/j.1600-065X.1990.tb00559.x
Hughes, 1992, Recruitment of CD11bCD18 to the neutrophil surface and adherence-dependent cell locomotion, J Clin Invest, 90, 1687, 10.1172/JCI116041
Arnaout, 1990, Structure and function of the leukocyte adhesion molecules CD11CD18, Blood, 75, 1037, 10.1182/blood.V75.5.1037.1037
Osborn, 1990, Leukocyte adhesion to endothelium in inflammation, Cell, 62, 3, 10.1016/0092-8674(90)90230-C
Luscinskas, 1991, Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1, J Immunol, 146, 1617, 10.4049/jimmunol.146.5.1617
Kukielka, 1995, Induction of interleukin-6 synthesis in the myocardium, Circulation, 92, 1866, 10.1161/01.CIR.92.7.1866
Kilbride, 1994, Induction of intercellular adhesion molecule-l- and E-selection mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass, J Thorac Cardiovasc Surg, 107, 1183
Hill, 1994, Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans, Anesth Analg, 79, 23, 10.1213/00000539-199407000-00006
Gillinov, 1993, Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators, Ann Thorac Surg, 56, 847, 10.1016/0003-4975(93)90342-F
Menasché, 1994, Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions?, Circulation, 90, 11275
Boldt, 1995, Circulating adhesion molecules in pediatric cardiac surgery, Anesth Analg, 81, 1129
Leeuwenberg, 1992, E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro, Immunology, 77, 543
Johnson, 1994, Neutrophil-mediated acute lung injury after extracorporeal circulation, J Thorac Cardiovasc Surg, 107, 1193, 10.1016/S0022-5223(94)70037-0
Dreyer, 1992, Neutrophil-mediated pulmonary injury in a canine model of cardiopulmonary bypass: Evidence for a CD 18-dependent mechanism, Circulation, 86, 2502
Gillinov, 1994, Inhibition of neutrophil adhesion during cardiopulmonary bypass, Ann Thorac Surg, 57, 126, 10.1016/0003-4975(94)90380-8
Wilson, 1993, Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart, Circulation, 88, 372
Byrne, 1992, Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion, J Thorac Cardiovasc Surg, 104, 1589, 10.1016/S0022-5223(19)33888-7
Simpson, 1988, Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (Anti-Mol, Anti-CD11b) that inhibits leukocyte adhesion, J Clin Invest, 81, 624, 10.1172/JCI113364
Entman, 1992, Neutrophil-induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence, J Clin Invest, 90, 1335, 10.1172/JCI115999
Smith, 1991, Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1, J Clin Invest, 88, 1216, 10.1172/JCI115424
Simon, 1986, Neutrophil-induced injury of rat pulmonary alveolar epithelial cells, J Clin Invest, 78, 1375, 10.1172/JCI112724
Craddock, 1977, Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis, N Engl J Med, 296, 769, 10.1056/NEJM197704072961401
Pearse, 1996, Vascular injury in isolated sheep lungs, Am J Respir Crit Care Med, 153, 196, 10.1164/ajrccm.153.1.8542116
Weyrich, 1993, In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury, J Clin Invest, 91, 2620, 10.1172/JCI116501
Larsen, 1989, PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes, Cell, 59, 305, 10.1016/0092-8674(89)90292-4
Rinder, 1991, Platelet activation and aggregation during cardiopulmonary bypass, Anesthesiology, 75, 388, 10.1097/00000542-199109000-00002
Hamburger, 1990, GMP-140 mediates adhesion of stimulated platelets to neutrophils, Blood, 75, 550, 10.1182/blood.V75.3.550.550
Todoroki, 1991, Enhancement by IL-1β and IFN-γ of platelet activation: Adhesion to leukocytes via GMP-140/PADGEM protein (CD62), Biochem Biophys Res Commun, 179, 756, 10.1016/0006-291X(91)91881-C
Rajagopalan, 1992, Tumor necrosis factor-α modulation of glycoprotein Ibα expression in human endothelial and erythroleukemia cells, Blood, 80, 153, 10.1182/blood.V80.1.153.153
Moncada, 1993, The L-arginine-nitric oxide pathway, N Engl J Med, 329, 2002, 10.1056/NEJM199312303292706
Belvisi, 1992, Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans, Eur J Pharm, 210, 221, 10.1016/0014-2999(92)90676-U
Kubes, 1991, Nitric oxide: An endogenous modulator of leukocyte adhesion, 88, 4651
Alican, 1996, A critical role for nitric oxide in intestinal barrier function and dysfunction, Am J Physiol, 270, G225
Wink, 1991, DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science, 254, 1001, 10.1126/science.1948068
Radi, 1991, Peroxynitrite oxidation of sulfhydryls, J Biol Chem, 266, 4244, 10.1016/S0021-9258(20)64313-7
Nijkamp, 1994, Nitric oxide and bronchial reactivity, Clin Exp Allergy, 24, 905, 10.1111/j.1365-2222.1994.tb02721.x
Kuo, 1992, The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways, Eur J Pharm, 221, 385, 10.1016/0014-2999(92)90728-M
Berisha, 1994, Nitric oxide as a mediator of oxidant lung injury due to paraquat, 91, 1
Folkerts, 1988, Endotoxin-induced inflammation and injury of the guinea pig respiratory airways cause bronchial hyporeactivity, Am Rev Respir Dis, 137, 1441, 10.1164/ajrccm/137.6.1441
Finkel, 1992, Negative inotropic effects of cytokines on the heart mediated by nitric oxide, Science, 257, 387, 10.1126/science.1631560
Doss, 1995, Mechanisms of systemic vasodilation during normovolemic hemodilution, Anesth Analg, 81, 30
Matheis, 1992, Role of 1-arginine-nitric oxide pathway in myocardial reoxygenation injury, Am J Physiol, 262, H616
Depre, 1995, Protection against ischemic injury by nonvasoactive concentrations of nitric oxide sythase inhibitors in the perfused rabbit heart, Circulation, 92, 1911, 10.1161/01.CIR.92.7.1911
Ma, 1995, Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion, Gastroenterology, 108, 463, 10.1016/0016-5085(95)90075-6
Boughton-Smith, 1993, The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat, Br J Pharmacol, 110, 1189, 10.1111/j.1476-5381.1993.tb13940.x
Thiemermann, 1994, Aminoguanidine attenuates the delayed circulatory failure in endotoxin and haemorrhagic shock in the anesthetized rat, Can J Physiol Pharmacol, 72, P14.2.22
Fukuda, 1995, Supplement of nitric oxide attenuates neutrophil mediated reperfusion injury, Circulation, 92, 11413, 10.1161/01.CIR.92.9.413
Ma, 1993, Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium, Circ Res, 72, 403, 10.1161/01.RES.72.2.403
Ignarro, 1993, Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: Comparison with enzymatically formed nitric oxide from I-arginine, 90, 8103
Ruvolo, 1994, Nitric oxide formation during cardiopulmonary bypass, Ann Thorac Surg, 57, 1055, 10.1016/0003-4975(94)90249-6
Delgado, 1995, Ca+2-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass, Thorax, 50, 403, 10.1136/thx.50.4.403
Kobzik, 1993, Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization, Am J Respir Cell Mol Biol, 9, 371, 10.1165/ajrcmb/9.4.371
Hill, 1995, Glucocorticoids reduce bronchial epithelial inflammation during cardiopulmonary bypass, Am J Respir Crit Care Med, 152, 1791, 10.1164/ajrccm.152.6.8520738
Massaro, 1995, Expired nitric oxide levels during treatment of acute asthma, Am J Respir Crit Care Med, 152, 800, 10.1164/ajrccm.152.2.7633745
McGowan, 1993, Cardiopulmonary bypass significantly reduces surfactant activity in children, J Thorac Cardiovasc Surg, 106, 968, 10.1016/S0022-5223(19)33967-4
Macnaughton, 1992, Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass, Crit Care Med, 20, 1289, 10.1097/00003246-199209000-00016
Roeise, 1989, Studies on the dose dependence of endotoxin-induced in vitro activation of the complement system, Eur Surg Res, 21, 34, 10.1159/000129001
Clardy, 1994, Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B, Infect Immun, 62, 4549, 10.1128/IAI.62.10.4549-4555.1994
van Deventer, 1991, Endotoxininduced neutrophil activation: The role of complement revisited, Prog Clin Biol Res, 367, 101
Grisham, 1988, Endotoxemia and neutrophil activation in vivo, Am J Physiol, 254, H1017
Burrell, 1990, Immunomodulation by bacterial endotoxin, Crit Rev Microbiol, 17, 189, 10.3109/10408419009105725
Witthaut, 1994, Complement and tumor necrosis factor-alpha contribute to Mac-1 (CD11bCD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo, J Leukoc Biol, 55, 105, 10.1002/jlb.55.1.105
Okusawa, 1987, C5a induction of human interleukin-1 synergistic effect with endotoxin or interferon-gamma, J immunol, 139, 2635, 10.4049/jimmunol.139.8.2635
Homeister, 1992, Effects of complement activation in the isolated heart, Circ Res, 71, 303, 10.1161/01.RES.71.2.303
Cavarocchi, 1986, Complement activation during cardiopulmonary bypass, J Thorac Cardiovasc Surg, 91, 252, 10.1016/S0022-5223(19)36089-1
Steinberg, 1993, Cytokine and complement levels in patients undergoing cardiopulmonary bypass, J Thorac Cardiovasc Surg, 106, 1008, 10.1016/S0022-5223(19)33971-6
Jansen, 1995, Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits, J Thorac Cardiovasc Surg, 110, 829, 10.1016/S0022-5223(95)70117-6
Niazi, 1979, Effects of glucocorticoids in patients undergoing coronary artery bypass surgery, Chest, 76, 262, 10.1378/chest.76.3.262
Andersen, 1989, The effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery, J Cardiothorac Anesth, 3, 544, 10.1016/0888-6296(89)90150-6
Hill, 1995, Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans, J Thorac Cardiovasc Surg, 110, 1658, 10.1016/S0022-5223(95)70027-7
Jansen, 1991, Inhibition of dexamethasone of the reperfusion phenomena in cardiopulmonary bypass, J Thorac Cardiovasc Surg, 102, 515, 10.1016/S0022-5223(20)31421-5
Jansen, 1991, The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass, Eur J Cardiothorac Surg, 5, 211, 10.1016/1010-7940(91)90032-F
Barber, 1990, Impact of hypercortisolemia on the metabolic and hormonal responses to endotoxin in humans, Surg Forum, 41, 74
Rock, 1992, Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans, Surgery, 112, 467
Huang, 1993, Effect of corticosteroids on IL1β and TNFα release by alveolar macrophages from patients with AIDS and pneumocystis carinii pneumonia, Chest, 104, 751, 10.1378/chest.104.3.751
Redl, 1987, Effect of methylprednisolone, prednisolone, and dexamethasone on granulocyte function and complement activation, Prog Clin Biol Res, 236B, 261
Zitnik, 1994, Glucocorticoid inhibition of interleukin-1 induced interleukin-6 production by human lung fibroblasts: Evidence for transcriptional and post-transcriptional regulatory mechanism, Am J Respir Cell Mol Biol, 10, 643, 10.1165/ajrcmb.10.6.7516173
Cronstein, 1992, A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1, 89, 9991
Radomski, 1990, Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells, 87, 10043
Knowles, 1990, Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver, and aorta of the rat, Biochem Biophys Res Commun, 172, 1042, 10.1016/0006-291X(90)91551-3
Rees, 1990, Dexamethasone prevents the induction of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock, Biochem Biophys Res Commun, 173, 541, 10.1016/S0006-291X(05)80068-3
Kharitonov, 1996, Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients, Am J Respir Crit Care Med, 153, 454, 10.1164/ajrccm.153.1.8542158
Bidstrup, 1989, Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol), J Thorac Cardiovasc Surg, 97, 364, 10.1016/S0022-5223(19)34573-8
Trapnell, 1974, A controlled trial of trasylol in the treatment of acute pancreatitis, Br J Surg, 61, 177, 10.1002/bjs.1800610303
Ogata, 1983, The effects of aprotinin on the phagocytic activity of the reticulo-endothelial system and plasma prekallikrein levels during endotoxin shock, Prog Clin Biol Res, 111, 309
McMichan, 1982, Prophylaxis of post-traumatic pulmonary insufficiency by proteinase inhibitor therapy with aprotinin: A clinical study, Circ Shock, 9, 107
Welbourn, 1991, Neutrophil elastase and oxygen radicals: Synergism in lung injury after hindlimb ischemia, Am J Physiol, 260, H1852
Nishiyama, 1996, The effect of ulinastatin, a human protease inhibitor, on the transfusion-induced increase of plasma polymorphonuclear granulocyte elastase, Anesth Analg, 82, 108
Sakamaki, 1996, Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury, Am J Respir Crit Care Med, 153, 391, 10.1164/ajrccm.153.1.8542148
Hughes, 1985, The effects of the protease inhibitor, aprotinin, on the course of shock induced by endotoxin in cats, Br J Pharmacol, 86, 399, 10.1111/j.1476-5381.1985.tb08909.x
Swartholm, 1989, Influence of aprotinin, a protease inhibitor, on porcine E. coli shock, Acta Chir Scand, 155, 7
Camussi, 1988, Synthesis and release of platelet-activating factor is inhibited by plasma a1-proteinase inhibitor or a1-antichymotrypsin and is stimulated by proteinase, J Exp Med, 168, 1293, 10.1084/jem.168.4.1293
Szabo, 1993, Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide, Circ Res, 73, 991, 10.1161/01.RES.73.6.991
Aoki, 1994, Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest, Ann Thorac Surg, 58, 146, 10.1016/0003-4975(94)91089-8
Hunyadi, 1993, Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alpha-mediated cytotoxicity on murine L929 tumor cells, Mol Immunol, 30, 517, 10.1016/0161-5890(93)90025-7
Kim, 1993, Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate, Immunology, 80, 134
Whitten, 1992, Does aprotinin inhibit cardiopulmonary bypass-induced inflammation?, Anesthesiology, 77, A266, 10.1097/00000542-199209001-00266
Wachtfogel, 1993, Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion, J Thorac Cardiovasc Surg, 106, 1, 10.1016/S0022-5223(19)33735-3
Lord, 1992, Effect of aprotinin on neutrophil function after major vascular surgery, Br J Surg, 79, 517, 10.1002/bjs.1800790614
Nishijima, 1992, Protease inhibitors (gabexate mesylate and ulinastatin) stimulate intracellular chemiluminescence in human neutrophils, J Leukoc Biol, 52, 262, 10.1002/jlb.52.3.262
Sawa, 1996, Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations, J Thorac Cardiovasc Surg, 111, 29, 10.1016/S0022-5223(96)70398-7
Wendel, 1995, Lower cardiac tropinin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage, J Thorac Cardiovasc Surg, 109, 1164, 10.1016/S0022-5223(95)70200-8
Kim, 1995, Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-KB, J Immunol, 154, 4741, 10.4049/jimmunol.154.9.4741
Royston, 1996, Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass, J Cardiovasc Pharmacol, 27, 542, 10.1097/00005344-199600001-00010
Shakhov, 1990, κB-type enhancers are involved in kipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages, J Exp Med, 171, 35, 10.1084/jem.171.1.35
Tumen, 1988, Antiproteases protect cultured lung endothelial cells from endotoxin injury, J Appl Physiol, 65, 835, 10.1152/jappl.1988.65.2.835
Kilbourn, 1990, Endothelial cell production of nitrogen oxides in response to IFN in combination with TNF, IL-1, or endotoxin, J Natl Cancer Inst, 82, 772, 10.1093/jnci/82.9.772
Radomski, 1987, The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium, Biochem Biophys Res Commun, 148, 1482, 10.1016/S0006-291X(87)80299-1
Menasché, 1995, Influence of temperature on neotrophil trafficking during clinical cardiopulmonary bypass, Circulation, 92, 11334, 10.1161/01.CIR.92.9.334
Le Deist, 1995, Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophilendothelial cell adhesion, Circulation, 92, 11354, 10.1161/01.CIR.92.9.354
Redmond, 1993, Heparin-coated bypass circuits reduce pulmonary injury, Ann Thorac Surg, 56, 474, 10.1016/0003-4975(93)90882-I
Morioka, 1996, Leukocyte and platelet depletion with a blood cell separator: Effects of lung injury after cardiac surgery with cardiopulmonary bypass, J Thorac Cardiovasc Surg, 111, 45, 10.1016/S0022-5223(96)70400-2
Steinberg, 1995, Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass, Ann Thorac Surg, 60, 525, 10.1016/0003-4975(95)00482-Z
Jansen, 1995, Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits, J Thorac Cardiovase Surg, 110, 829, 10.1016/S0022-5223(95)70117-6
Naik, 1991, A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery, Circulation, 84, 422
Elliott, 1993, Ultrafiltration and modified ultrafiltration in pediatric open heart operations, Ann Thorac Surg, 56, 1518, 10.1016/0003-4975(93)90744-3
Millar, 1993, Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass, Ann Thorac Surg, 56, 1499, 10.1016/0003-4975(93)90740-9
Mink, 1995, Effect of continuous arteriovenous hemofiltration combined with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis, Anesthesiology, 83, 178, 10.1097/00000542-199507000-00021
Vincent, 1995, Continuous hemofiltration in severe sepsis: Is it beneficial?, J Crit Care, 10, 27, 10.1016/0883-9441(95)90028-4
Mathew, 1995, Acadesine inhibits neutrophil CD1 lb upregolation in vitro and during in vivo cardiopulmonary bypass, J Thorac Cardiovasc Surg, 109, 448, 10.1016/S0022-5223(95)70275-X
Galinanes, 1992, Sustained protection by acadesine against ischemia and reperfusion-induced injury, Circulation, 86, 589, 10.1161/01.CIR.86.2.589
Olafsson, 1987, Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon, Circulation, 76, 1135, 10.1161/01.CIR.76.5.1135
Cronstein, 1986, Adenosine: An endogenous inhibitor of neutrophil-mediated injury to endothelial cells, J Clin Invest, 78, 760, 10.1172/JCI112638
Gruber, 1989, Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: Effects on flow, granulocytes, and injury, Circulation, 80, 1400, 10.1161/01.CIR.80.5.1400
Stewart, 1993, Adenosine inhibits platelet-activating factor, but not tumor necrosis factor-α-induced priming of human neutrophils, Immunology, 78, 152
Cronstein, 1994, Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: Adenosine dependent and independent mechanisms, Inflammation, 18, 323, 10.1007/BF01534273
Leung, 1994, An initial, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery, Anesth Analg, 78, 420, 10.1213/00000539-199403000-00002
Lane, 1986, Increased infection mortality and decreased neutrophil migration due to a component of an artificial blood substitute, Blood, 68, 351, 10.1182/blood.V68.2.351.351
Babbitt, 1990, Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical, Am J Pathol, 136, 451
Smith, 1993, Effect of a high concentration perflubron emulsion on platelet function, Biomater Art Cells Immob Biotech, 21, 173
Vercellotti, 1982, Activation of plasma complement by perfluorocarbon artificial blood: Probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis, Blood, 59, 1299, 10.1182/blood.V59.6.1299.1299
Naccache, 1994, Regulation of stimulated integrin surface expression in human neutrophils by tyrosine phosphorylation, Blood, 84, 616, 10.1182/blood.V84.2.616.616
Kaneko, 1994, Leumedin NPC 15669 inhibits antigen-induced recruitment of inflammatory cells into the canine airways, Am J Physiol, 267, L250